Showing results (1121-1130 of 4,879) with videos related to
Sort By:
Pageof 488
Urologic Oncology|May 24, 2021
Artificial intelligence in urological oncology: An update and future applicationsAndrew Brodie, Nick Dai, Jeremy Yuen-Chun Teoh, et al.Urologic Oncology|June 28, 2026
Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4-5 lesionsCassandra Jeavons, Kevin An, Yilin Zhang, et al.Urologic Oncology|July 11, 2026
Impact of number of bone metastases on cancer control outcomes in mHSPC, independent of the axial-skeleton CHAARTED definitionMike Wenzel, Lena Theissen, Carolin Siech, et al.Urologic Oncology|July 11, 2026
Enfortumab vedotin monotherapy, enfortumab vedotin plus pembrolizumab, and immune checkpoint inhibitor-based neoadjuvant therapy for muscle-invasive bladder cancer: A systematic review and meta-analysisShugo Yajima, Soichiro Yoshida, Naoki Imasato, et al.Urologic Oncology|July 9, 2026
Automated algorithm for surgical outcomes abstraction for cystectomyPeter S Palencia, Brandon L Ward, Maximilian J Rabil, et al.Urologic Oncology|July 9, 2026
Comparative effectiveness of intravesical gemcitabine vs. sequential gemcitabine and docetaxel for high-risk nonmuscle-invasive bladder cancerJacob A Moyer, Mahnoor Ashraf, Lanyu Mi, et al.Urologic Oncology|July 11, 2026
Biopsy-to-treatment delay in prostate cancer: Postpandemic impact in a swiss national, multicenter, prospective registryTimon Winistoerfer, Simone Scuderi, Giorgio Gandaglia, et al.Urologic Oncology|July 11, 2026
Efficacy and safety of first-line immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients on hemodialysisHidetsugu Takahashi, Wataru Fukuokaya, Takafumi Yanagisawa, et al.Urologic Oncology|June 16, 2009
Second opinion pathology in tertiary care of patients with urologic malignanciesRobert O Wayment, Andrew Bourne, Paul Kay, et al.Urologic Oncology|August 3, 2026
Beyond androgen deprivation therapy: Next-generation hormonal therapies and emerging combination approaches in advanced prostate cancerGabrielle Paras, Michael T SchweizerPageof 488